New Partnership to Test Advanced Gene Therapy for Hard-to-Treat Epilepsy
EpilepsyGTx, a company working on new treatments for epilepsy, has teamed up with ClearPoint Neuro to use a specialized tool […]
EpilepsyGTx, a company working on new treatments for epilepsy, has teamed up with ClearPoint Neuro to use a specialized tool […]
Pharmacists and companies that hold Certificates of Suitability for European Pharmacopoeia (CEP) are being asked to review and provide feedback
A major new clinical trial called PRECISE-HD has started to test whether a drug called pridopidine can help people with
A major update was shared at the ISSCR 2026 Annual Meeting about the first clinical trial testing a new treatment
Grünenthal, a pharmaceutical company, has announced that the U.S. Food and Drug Administration (FDA) has given two special designations to
Lonza, a leading company in pharmaceutical manufacturing, is investing in its facility located in Visp, Switzerland, to meet the growing
A pharmaceutical company called Compass Pathways has shared positive six-month results from a large study testing a new depression treatment.
The Francis Crick Institute, in partnership with Medicines Discovery Catapult and Cancer Research Horizons, has opened applications for the ninth
A major healthcare initiative in the UAE has just begun a first-of-its-kind clinical trial that uses genetic testing to try
During the CPHI Barcelona conference in October, European Pharmaceutical Review spoke with Julien Lamps, an expert from Lonza CHI, about